The main results achieved and the development prospects of the Cuban Biotechnological and Pharmaceutical Industries Group (BioCubaFarma), was the topic addressed by its president, Dr. Eduardo Martínez, who heads a representation of the creators of the Cuban anti-COVID-19 vaccines, in visit to Holguín.

The Cuban Ministry of Public Health (Minsap) reported today the death of the first patient, of Italian nationality, detected with monkeypox in the island.

The province of Holguín is facing a complex epidemiological situation due to the increase in positives for COVID-19 and dengue transmission in several municipalities.

The head of the Theragnostic Laboratory of the Havana-based Calixto Garcia University Hospital (Ceaden), Tania Valdes, presented here the natural drug Curmeric, which has been administered in Cuba in the context of Covid-19.